Shogo Kobayashi

Shogo Kobayashi

Auto-generated profile, based on publicly available information

Shogo Kobayashi

Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2010 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
KMKazuhiro Mochizuki
Kazuhiro Mochizuki
AKAtsushi Kikuta
Atsushi Kikuta
MIMasaki Ito
Masaki Ito
HSHideki Sano
Hideki Sano
MAMitsuko Akaihata
Mitsuko Akaihata
MHMitsuaki Hosoya
Mitsuaki Hosoya

1 July 2020 in The Astrophysical Journal
Verified
Journal Article
Closed access
KFKotaro Fukushima
Kotaro Fukushima
HYHiroya Yamaguchi
Hiroya Yamaguchi
PSPatrick Slane
Patrick Slane
SPSangwook Park
Sangwook Park
SKSatoru Katsuda
Satoru Katsuda
KMKyoko Matsushita
Kyoko Matsushita
Despite their importance, a detailed understanding of Type Ia supernovae (SNe Ia) remains elusive. X-ray measurements of the element distributions in supernova remnants (SNRs) offer important clues for understanding the explosion and nucleosynthesis mechanisms for SNe Ia. However, it is challenging to observe the entire ejecta mass in X-rays for young SNRs, because the central ejecta may not have been heated by the reverse shock yet. Here we present over 200 kilosecond Chandra observations of the Type Ia SNR G344.7–0.1, whose age is old enough for the reverse shock to have reached the SNR center, providing an opportunity to investigate the distribution of the entire ejecta mass. We reveal a clear stratification of heavy elements with a centrally peaked distribution of the Fe ejecta surrounded by intermediate-mass elements (IMEs: Si, S, Ar Ca) with an arc-like structure. The centroid energy of the Fe K emission is marginally lower in the central Fe-rich region than in the outer IME-rich regions, suggesting that the Fe ejecta were shock-heated more recently. These results are consistent with the prediction for standard SN Ia models, where the heavier elements are synthesized in the interior of an exploding white dwarf. We find, however, that the peak location of the Fe K emission is slightly offset to the west with respect to the geometric center of the SNR. This apparent asymmetry is likely due to the inhomogeneous density distribution of the ambient medium, consistent with our radio observations of the ambient molecular and neutral gas.

27 September 2017 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
SKShogo Kobayashi
Shogo Kobayashi
HSHideki Sano
Hideki Sano
KMKazuhiro Mochizuki
Kazuhiro Mochizuki
YOYoshihiro Ohara
Yoshihiro Ohara
NTNobuhisa Takahashi
Nobuhisa Takahashi
AKAtsushi Kikuta
Atsushi Kikuta

25 January 2014 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
SKShogo Kobayashi
Shogo Kobayashi
AKAtsushi Kikuta
Atsushi Kikuta
MIMasaki Ito
Masaki Ito
HSHideki Sano
Hideki Sano
KMKazuhiro Mochizuki
Kazuhiro Mochizuki
MHMitsuaki Hosoya
Mitsuaki Hosoya

1 May 2011 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
YTYoshito Tomimaru
Yoshito Tomimaru
HEHidetoshi Eguchi
Hidetoshi Eguchi
HWHiroshi Wada
Hiroshi Wada
ATAkira Tomokuni
Akira Tomokuni
SKShogo Kobayashi
Shogo Kobayashi
HNHiroaki Nagano
Hiroaki Nagano
Interferon (IFN)-ß is reported to have more potent antitumor effects than IFN-α. The aim of this study was to compare the synergistic antitumor activity of both IFNs when combined with gemcitabine on cultured pancreatic cancer cells expressing various levels of IFN receptor. The growth-inhibitory effects of IFN-α and IFN-ß in combination with gemcitabine on three human pancreatic cancer cell lines (BxPC-3, MIAPaCa-2, Panc-1) were evaluated by MTT assay and isobolographic analysis. We also correlated their growth-inhibitory effects with the expression status of type I IFN receptor type 2 (IFNAR2). Western blot analysis indicated strong expression of IFNAR2 in BxPC-3 and MIAPaCa-2, but weak expression in Panc-1. The growth-inhibitory effect of gemcitabine was enhanced synergistically by IFN-α in BxPC-3 and MIAPaCa-2, but not in Panc-1. IFN-ß exhibited more potent synergistic growth-inhibitory effects with gemcitabine in BxPC-3 and MIAPaCa-2 compared to IFN-α, and also synergistic enhancement in Panc-1. In conclusion, our results indicated that the growth-inhibitory effect of IFN-ß with gemcitabine was synergistic not only in pancreatic cancer cells with strong expression of IFNAR2, but also in those with weak expression of IFNAR2.

30 November 2020 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
NTNobuhisa Takahashi
Nobuhisa Takahashi
KMKazuhiro Mochizuki
Kazuhiro Mochizuki
HSHideki Sano
Hideki Sano
SKShogo Kobayashi
Shogo Kobayashi
YOYoshihiro Ohara
Yoshihiro Ohara
AKAtsushi Kikuta
Atsushi Kikuta